Physician profile
Alyssa D Wait
NPI 1659698058
$6,470.68
in general payments reported to CMS, 2019-2025
15 companies · $20.71 in 2025
The $20.71 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,905 · 2020: $83.36 · 2021: $82.53 · 2022: $1,355 · 2023: $24.24 · 2025: $20.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $44.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $44.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,730.30 | 2019-2022 | |
| Conmed Corporation | $300.00 | 2019 | |
| Braintree Laboratories, INC. | $102.20 | 2019-2021 | |
| Ethicon US, LLC | $68.10 | 2019-2022 | |
| Tetraphase Pharmaceuticals, INC. | $61.57 | 2019 | |
| Covidien LP | $35.71 | 2019 | |
| Teleflex LLC | $32.25 | 2020 | |
| Heron Therapeutics, INC. | $24.24 | 2023 | Zynrelef |
| Integra Lifesciences Corporation | $22.38 | 2019 | |
| Boston Scientific Corporation | $20.71 | 2025 | Overstitch Endoscopic Suturing System |
| Smith+Nephew, INC. | $16.41 | 2020 | |
| Merck Sharp & Dohme LLC | $16.07 | 2019 | |
| Acell, INC. | $14.08 | 2019 | |
| Lsi Solutions INC | $13.88 | 2020 | |
| Shire North American Group INC | $12.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Wait listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.